NCT00883935 - GSK1349572 Drug Interaction Study With Atazanavir/Ritonavir and Atazanavir | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions

Healthy Volunteer

Interventions

DRUG

GSK1349572

GSK1349572 30 mg once a day for 5 days in Period 1 and 14 days in Period 2

DRUG

Atazanavir 300 mg

Atazanavir 300 mg once per day for 14 days in Period 2

DRUG

Atazanavir 400 mg

Atazanavir 400 mg once a day for 14 days in Period 2

DRUG

Ritonavir

Ritonavir 100 mg once a day for 14 days in Period 2

Trial Locations (1)

GSK Investigational Site, Austin